體外膜氧合系統市場－全球產業規模、佔有率、趨勢、機會及預測（按模式、應用、最終用戶、地區和競爭細分，2020-2030 年）

2024 年全球體外膜氧合 (ECMO) 系統市值為 5.712 億美元，預計到 2030 年將達到 7.8248 億美元，複合年成長率為 5.36%。由於重症監護環境中對先進生命維持技術的需求不斷成長，體外膜氧合 (ECMO) 系統市場正在經歷顯著擴張。 ECMO 系統透過提供長時間的體外循環和氧合，在治療嚴重心臟和呼吸衰竭患者方面發揮至關重要的作用。醫療保健專業人員對 ECMO 在提高存活率方面的有效性的認知不斷提高，促進了其廣泛應用。即時監控、緊湊設計和自動化等創新功能的整合進一步提高了系統效能和可用性。心血管疾病、呼吸系統疾病和器官衰竭病例的增加推動了對 ECMO 的需求，尤其是在重症監護病房 (ICU) 和專門的心臟中心。醫療技術的進步也改善了患者的治療效果，使 ECMO 成為危及生命情況下的首選干預措施。

ECMO 技術的進步正在重塑市場，推動攜帶式和方便用戶使用系統的發展。不斷增加的研發投入使得設備效率提升、併發症減少、病人安全性提升。人們對微創和經皮 ECMO 插管技術的日益青睞降低了手術風險，並擴大了 ECMO 在傳統醫院環境之外的適用性。越來越多的心臟和肺移植手術也需要使用 ECMO 進行圍手術期支持，進一步推動市場成長。人工智慧 (AI) 和資料分析的整合正在幫助臨床醫生監測和最佳化 ECMO 性能，從而更好地管理患者。已開發國家優惠的報銷政策正在提高患者獲得ECMO治療的機會，而對新生兒和兒科護理的日益關注正在擴大目標患者群體。醫療保健提供者和醫療器材製造商之間的合作正在加速 ECMO 系統的採用，特別是在重症監護基礎設施正在快速發展的新興市場。

主要市場促進因素

醫療科技的進步

主要市場挑戰

高成本和資源密集型

主要市場趨勢

技術進步和小型化

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第 5 章：全球體外膜氧合 (ECMO) 系統市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依方式（靜脈-動脈 (VA)、靜脈-靜脈 (VV)、其他）
  • 依應用（呼吸應用、心臟應用、體外心肺復甦術 (ECPR)）
  • 按最終使用者（醫院和診所、門診護理中心、其他）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美體外膜氧合（ECMO）系統市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 加拿大
  • 墨西哥

第7章：歐洲體外膜氧合（ECMO）系統市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太體外膜氧合（ECMO）系統市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲體外膜氧合（ECMO）系統市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲體外膜氧合 (ECMO) 系統市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 促進因素與挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 合併與收購

第 13 章：全球體外膜氧合 (ECMO) 系統市場：SWOT 分析

第 14 章：競爭格局

• LivaNova（Alung Technologies Inc.）
• 歐元套
• 潔定公司
• 美敦力公司
• 微創科學有限公司
• 尼普洛醫療公司
• 泰爾茂醫療公司
• 雅培實驗室
• 費森尤斯醫療保健公司

第 15 章：策略建議

第16章調查會社について,免責事項

Global Extra Corporeal Membrane Oxygenation (ECMO) System Market was valued at USD 571.20 Million in 2024 and is expected to reach USD 782.48 Million in the forecast period with a CAGR of 5.36% through 2030. The Extracorporeal Membrane Oxygenation (ECMO) System Market is experiencing significant expansion due to the growing demand for advanced life-support technologies in critical care settings. ECMO systems play a crucial role in managing patients with severe cardiac and respiratory failure by providing prolonged extracorporeal circulation and oxygenation. Increased awareness among healthcare professionals regarding the effectiveness of ECMO in improving survival rates has contributed to its widespread adoption. The integration of innovative features such as real-time monitoring, compact designs, and automation is further enhancing system performance and usability. Rising cases of cardiovascular diseases, respiratory disorders, and organ failure are driving the need for ECMO, particularly in intensive care units (ICUs) and specialized cardiac centers. Advancements in medical technologies are also improving patient outcomes, making ECMO a preferred intervention in life-threatening conditions.

Advancements in ECMO technology are reshaping the market, leading to the development of portable and user-friendly systems. Increasing investments in research and development have resulted in devices with enhanced efficiency, reduced complications, and improved patient safety. The growing preference for minimally invasive and percutaneous ECMO cannulation techniques has reduced procedural risks and expanded the applicability of ECMO beyond traditional hospital settings. An increasing number of heart and lung transplant procedures also necessitate the use of ECMO for perioperative support, further driving market growth. The integration of artificial intelligence (AI) and data analytics is helping clinicians monitor and optimize ECMO performance, leading to better patient management. Favorable reimbursement policies in developed countries are enhancing patient access to ECMO therapy, while the growing focus on neonatal and pediatric care is expanding the target patient population. Collaborations between healthcare providers and medical device manufacturers are accelerating the adoption of ECMO systems, particularly in emerging markets where critical care infrastructure is rapidly developing.

Key Market Drivers

Advancements in Medical Technology

Advancements in medical technology have significantly enhanced extracorporeal membrane oxygenation (ECMO) systems, improving their efficacy, safety, and overall utility. These innovations are particularly crucial given the rising prevalence of cardiovascular diseases (CVDs) and respiratory failures, which are leading causes of mortality globally.

In the United States, heart disease remains the leading cause of death, accounting for 702,880 fatalities in 2022, which represents 1 in every 5 deaths. Coronary heart disease (CHD) is the most common type, responsible for 371,506 deaths in the same year. Additionally, about 1 in 20 adults aged 20 and older have CHD. Each year, approximately 805,000 Americans experience a heart attack, with 605,000 being first occurrences and 200,000 happening in individuals who have already had a heart attack.

Key Market Challenges

High Costs and Resource Intensity

ECMO therapy is a highly specialized and resource-intensive medical intervention. The equipment itself is expensive, and the overall cost of ECMO treatment includes not only the machine but also the required disposables, personnel, and infrastructure. Running an ECMO program demands a skilled team of healthcare professionals, including perfusionists and specially trained nurses, as well as dedicated facilities with the necessary technology and expertise.

Financial Burden: The high upfront costs associated with establishing and maintaining an ECMO program can be a substantial financial burden for healthcare institutions, particularly smaller hospitals and clinics. Due to the resource-intensive nature of ECMO, it may not be readily available in all healthcare settings, limiting access for patients in remote areas or regions with fewer healthcare resources. The cost barrier can exacerbate healthcare disparities, as not all patients may have equal access to ECMO treatment, potentially leading to unequal outcomes based on socioeconomic factors.

Key Market Trends

Technological Advancements and Miniaturization

One prominent trend in the global ECMO System Market is the continuous advancement of technology and the development of more compact, portable ECMO systems. This trend aims to make ECMO therapy more accessible and versatile.

Miniaturized ECMO Machines: Manufacturers are working on creating smaller, more portable ECMO machines that are easier to transport and set up. This makes ECMO treatment feasible in a wider range of healthcare settings, including ambulances and remote clinics. ECMO systems are increasingly being integrated with advanced monitoring devices and artificial intelligence algorithms. This integration allows for real-time monitoring of patient vitals, helping healthcare providers make informed decisions and detect complications earlier. Some ECMO systems now offer wireless connectivity, enabling healthcare teams to monitor patients remotely. This feature is especially valuable for critical care patients who require continuous monitoring even during inter-hospital transfers.

Key Market Players

• LivaNova (Alung Technologies Inc.)
• Eurosets
• Getinge AB
• Medtronic PLC
• Microport Scientific Corporation
• Nipro Medical Corporation
• Terumo Medical Corporation
• Abbott Laboratories
• Fresenius Medical Care Company

Report Scope:

In this report, the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Modality:

• Veno-Arterial (VA)
• Veno-Venous (VV)
• Others

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Application:

• Respiratory Applications
• Cardiac Applications
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By End-User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market.

Available Customizations:

Global Extra Corporeal Membrane Oxygenation (ECMO) System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Modality (Veno-Arterial (VA), Veno-Venous (VV), Others)
  • 5.2.2. By Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR))
  • 5.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Modality
  • 6.2.2. By Application
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Modality
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Modality
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Modality
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-User

7. Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Modality
  • 7.2.2. By Application
  • 7.2.3. By End-User
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Modality
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-User
  • 7.3.2. United Kingdom Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Modality
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-User
  • 7.3.3. Italy Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Modality
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-User
  • 7.3.4. France Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Modality
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Modality
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-User

8. Asia-Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Modality
  • 8.2.2. By Application
  • 8.2.3. By End-User
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Modality
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Modality
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Modality
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Modality
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Modality
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-User

9. South America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Modality
  • 9.2.2. By Application
  • 9.2.3. By End-User
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Modality
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-User
  • 9.3.2. Argentina Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Modality
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-User
  • 9.3.3. Colombia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Modality
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-User

10. Middle East and Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Modality
  • 10.2.2. By Application
  • 10.2.3. By End-User
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Modality
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-User
  • 10.3.2. Saudi Arabia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Modality
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-User
  • 10.3.3. UAE Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Modality
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers & Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market: SWOT Analysis

14. Competitive Landscape

• 14.5.1. LivaNova (Alung Technologies Inc.)
• 14.5.2. Eurosets
• 14.5.3. Getinge AB
• 14.5.4. Medtronic PLC
• 14.5.5. Microport Scientific Corporation
• 14.5.6. Nipro Medical Corporation
• 14.5.7. Terumo Medical Corporation
• 14.5.8. Abbott Laboratories
• 14.5.9. Fresenius Medical Care Company

15. Strategic Recommendations

16. About Us & Disclaimer